Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate.

The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate. J Surg Oncol. 1983 Jun; 23(2):133-42.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.